
French biopharmaceutical company Inventiva SA on Thursday revealed it has expanded its U.S. share sale to approximately $150 million, as the clinical-stage firm detailed its plans to use the capital t...
French biopharmaceutical company Inventiva SA on Thursday revealed it has expanded its U.S. share sale to approximately $150 million, as the clinical-stage firm detailed its plans to use the capital t...